JMP Securities Starts CTI BioPharma (CTIC) at Market Outperform

March 7, 2018 3:52 AM
JMP Securities initiates coverage on CTI BioPharma (NASDAQ: CTIC) with a Market Outperform rating and a price target of $8.00.Analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot New Coverage New Coverage